Exelixis, Inc.(EXEL)- NASDAQ
Company Description
Exelixis, Inc. is a biopharmaceutical company, which engages in the developing and commercializing small molecule therapies for the treatment of cancer. Its brands include COMETRIQ and cobimetinib. The company focuses on their proprietary resources and development and commercialization of... More
Sector: Healthcare
Industry: Biotechnology
Country: United States